Related Experiment Video
Updated: Nov 2, 2025

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Hypoglycemia and jaundice in newborns with pituitary stalk interruption syndrome
Qi Wang1, Xiangji Meng2, Yan Sun1
1Department of Paediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan.
Insights
Neonatal Pituitary stalk interruption syndrome (PSIS) presents with hypoglycemia and jaundice, not dwarfism. Early diagnosis and hormone therapy are crucial for a good prognosis in affected newborns.
Area of Science:
- Pediatric Endocrinology
- Rare Diseases
- Neonatal Medicine
Background:
- Pituitary stalk interruption syndrome (PSIS) is a rare condition often associated with growth hormone deficiency.
- Neonatal PSIS is exceptionally rare and challenging to diagnose due to the absence of typical short stature.
- Undiagnosed neonatal PSIS can be life-threatening.
Purpose of the Study:
- To identify and characterize neonatal PSIS cases.
- To improve early diagnosis of neonatal PSIS.
- To outline clinical features and treatment outcomes.
Main Methods:
- Retrospective analysis of three neonatal PSIS patients treated between January 2017 and July 2020.
- Collection of clinical data, endocrine hormone levels, and pituitary MRI findings.
- Assessment of response to hormone replacement therapy and follow-up.
Main Results:
- Three neonatal patients with PSIS were identified.
- Key features included hypoglycemia, jaundice, combined pituitary hormone deficiency (CPHD) with micropenis and hypothyroidism.
- Genetic causes were difficult to determine.
- All patients responded well to hormone therapy, with follow-up up to 3 years.
Conclusions:
- Persistent hypoglycemia and jaundice in newborns can indicate PSIS.
- Early recognition and intervention are vital for preventing life-threatening complications.
- Hormone replacement therapy ensures a positive prognosis for neonatal PSIS.
Abstract:
Pituitary stalk interruption syndrome (PSIS) is a rare disease associated with either isolated growth hormone deficiency (GHD) or combined pituitary hormone deficiency (CPHD). In older children and adults, most patients experience short stature or hypogonadism. Neonatal PSIS is extremely rare and is difficult to recognize due to absence of dwarfism. However, when this condition occurs in newborns, it is often life-threatening. Here, we collected patients with neonatal PSIS to clarify its characteristics to improve its early diagnosis.The patients included in this study were treated at the pediatric endocrine department of Shandong Provincial Hospital from January 2017 to July 2020. We obtained the clinical characteristics, endocrine hormone levels, pituitary magnetic resonance imaging (MRI) and further genetic data for all the patients. Hormone therapy was first given at the time of diagnosis, and the patients received regular follow-up.Three neonatal patients were identified in our clinic. The characteristics of these patients included hypoglycemia and jaundice, as well as CPHD, which included features such as micropenis and hypothyroidism. Genetic etiology was still hard to discover. All the patients responded well to alternative therapy, and the longest follow-up period was 3 years. Regular replacement ensures good prognosis.Sustained hypoglycemia and jaundice in newborns, indicate the presentation of PSIS. Early recognition is of great importance to avoid a life-threatening crisis.
Related Concept Videos
Hypoglycemia and Glucagon
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

